File photo of an Amgen sign at the company’s office FILE PHOTO: An Amgen sign is seen at the company’s office in South San Francisco, California in this October 21, 2013 file photo. REUTERS/Robert Galbraith/ Post navigation Previous: Analysis-Amgen’s antitrust woes spur wider pharmaceutical deal fears